Geode Capital Management LLC Acquires 35,544 Shares of Axon Enterprise, Inc $AXON

Key Points

• Geode Capital Management increased its Axon Enterprise stake by 1.6% in Q4, buying 35,544 shares and bringing its total holding to 2.23 million shares worth about $1.27 billion.
• Axon’s latest quarterly results beat expectations, with EPS of $1.61 versus $1.60 expected and revenue of $807.35 million, up 33.7% from a year earlier.
• The stock has drawn mixed signals: analysts remain broadly constructive with a Moderate Buy consensus and $712.75 average target, while some insiders have recently sold shares.

Geode Capital Management LLC boosted its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 1.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,226,159 shares of the biotechnology company's stock after acquiring an additional 35,544 shares during the period. Geode Capital Management LLC owned 2.82% of Axon Enterprise worth $1,265,657,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Evergreen Capital Management LLC raised its stake in Axon Enterprise by 3.8% in the 2nd quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company's stock valued at $342,000 after acquiring an additional 15 shares during the period. Wealth Alliance LLC raised its stake in Axon Enterprise by 3.2% in the 3rd quarter. Wealth Alliance LLC now owns 583 shares of the biotechnology company's stock valued at $419,000 after acquiring an additional 18 shares during the period. Quadrant Capital Group LLC raised its stake in Axon Enterprise by 0.5% in the 3rd quarter. Quadrant Capital Group LLC now owns 3,968 shares of the biotechnology company's stock valued at $2,848,000 after acquiring an additional 19 shares during the period. CWA Asset Management Group LLC raised its stake in Axon Enterprise by 5.2% in the 4th quarter. CWA Asset Management Group LLC now owns 387 shares of the biotechnology company's stock valued at $220,000 after acquiring an additional 19 shares during the period. Finally, Synergy Financial Group LTD raised its stake in Axon Enterprise by 1.4% in the 3rd quarter. Synergy Financial Group LTD now owns 1,388 shares of the biotechnology company's stock valued at $996,000 after acquiring an additional 19 shares during the period. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Axon Enterprise news, CAO Jennifer H. Mak sold 1,500 shares of Axon Enterprise stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $573.45, for a total transaction of $860,175.00. Following the completion of the transaction, the chief accounting officer owned 12,240 shares of the company's stock, valued at $7,019,028. The trade was a 10.92% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Isaiah Fields sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $400.00, for a total value of $800,000.00. Following the transaction, the insider directly owned 52,813 shares of the company's stock, valued at $21,125,200. The trade was a 3.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 3,855 shares of company stock worth $1,837,408 over the last quarter. 4.20% of the stock is owned by corporate insiders.

Axon Enterprise Stock Up 12.3%

AXON stock opened at $439.32 on Friday. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $35.41 billion, a PE ratio of 176.43, a PEG ratio of 7.11 and a beta of 1.44. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91. The stock has a 50-day simple moving average of $408.72 and a two-hundred day simple moving average of $494.98.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, beating analysts' consensus estimates of $1.60 by $0.01. The business had revenue of $807.35 million during the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company's quarterly revenue was up 33.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.47 EPS. On average, equities analysts predict that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Wall Street Analyst Weigh In

AXON has been the topic of a number of research reports. Robert W. Baird set a $800.00 price objective on Axon Enterprise in a research note on Wednesday, February 25th. Wall Street Zen upgraded Axon Enterprise from a "sell" rating to a "hold" rating in a research note on Saturday, February 28th. Royal Bank Of Canada lowered their price objective on Axon Enterprise from $860.00 to $735.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 25th. Needham & Company LLC lowered their price objective on Axon Enterprise from $870.00 to $600.00 and set a "buy" rating on the stock in a research note on Friday, February 20th. Finally, Citizens Jmp lowered their price objective on Axon Enterprise from $825.00 to $700.00 and set a "market outperform" rating on the stock in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $712.75.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon’s stronger-than-expected Q1 results and raised 2026 revenue outlook reinforced confidence in accelerating growth. Axon rallies 12% as upbeat 2026 outlook and fresh price-target hike lift sentiment
• Positive Sentiment: A major Wall Street firm raised its price target to $755, helping support bullish sentiment around the stock. Axon rallies 12% as upbeat 2026 outlook and fresh price-target hike lift sentiment
• Positive Sentiment: Axon’s partnership with Echodyne expanded its public safety drone and radar ecosystem, adding another growth catalyst. Echodyne Expands Public Safety Radar Applications Through Partnership with Axon
• Neutral Sentiment: Investor attention remains elevated, but recent Zacks headlines were mainly commentary rather than new fundamental news. Axon Enterprise, Inc (AXON) is Attracting Investor Attention: Here is What You Should Know
• Neutral Sentiment: Analyst coverage remains broadly supportive, with several buy ratings and a high consensus target, reinforcing the longer-term bull case. Axon Enterprise Stock: Analyst Estimates & Ratings
• Negative Sentiment: Recent insider selling may temper enthusiasm for some investors, even though it does not change the company’s operating outlook. Insider Selling: Axon Enterprise NASDAQ: AXON Insider Sells 2,000 Shares of Stock

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.